loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2241751 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 IMIGLUCERASE (1)

    filter

    01 SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC (1)

    filter

    01 POWDER FOR SOLUTION (1)

    filter

    01 400UNIT/VIAL (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Imiglucerase

    PDF Supplier PDF
    URL Supplier Web Content
    POWDER FOR SOLUTION
    400UNIT/VIAL
    CEREZYME
    Canada
    2241751
    10.6ML
    Prescription
    Sanofi Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier

    Looking for CTD TGA MCC DOSSIER APPLICATION 2241751

    Looking for CTD TGA MCC DOSSIER APPLICATION 2241751 1

    19

    Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    One of their notable products is IMIGLUCERASE, with a corresponding application number 2241751 and regulatory information .

    proudly manufactured in the

    Sanofi's CEREZYME POWDER FOR SOLUTION, medication with 400UNIT/VIAL of IMIGLUCERASE.

    Post Enquiry
    POST ENQUIRY